Therefore, compared with TAAs, tumour neoantigens are not affected by central immune tolerance, may induce a strong and persistent antitumour immune response, and have strong affinity for MHC molecules and T cell receptors (TCRs) [26]. Here, HLA-C is linked to neoplasm.